## Abstract ## BACKGROUND: Both concomitant chemotherapy and altered fractionation radiotherapy (RT) have been shown to improve outcomes for patients with locoregionally advanced head and neck squamous cell carcinomas. However, both strategies also increase acute toxicity, and it is questionable w
Concomitant cisplatin and radiationtherapy in advanced head and neck cancers:
β Scribed by N. R. Tulsi; R. K. Roul; F. R. Viswanathan
- Publisher
- Springer
- Year
- 1999
- Tongue
- English
- Weight
- 517 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0019-5421
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In 22 patients with advanced squamous cell carcinoma of the head and neck we evaluated the efficacy and toxicity of 200 mg/m2 cisplatin administered in 3% NaCl with vigorous hydration. Six patients had previously untreated stage IV disease and 16 patients had recurrent disease, including eight with
## Purpose: The purpose of this study was to evaluate the efficacy of rapid superselective high-dose cisplatin infusion with concomitant radiotherapy for previously untreated patients with advanced head and neck cancer. ## Methods: Forty-three patients for whom surgery was contraindicated or who
## Abstract ## Background. The purpose of this study was to study the effect of intensive targeted chemoradiation in a group of patients with head and neck cancer with stage IV inoperable disease. ## Methods. We examined 79 patients with inoperable stage IV head and neck cancer receiving intraβa
Background. The purpose of this study was to analyze long-term follow-up of a single institution's experience with a regimen of concomitant cisplatin/fluorouracil (5-FU) infusion and radiation given every other week. This analysis was stimulated by results of a randomized trial showing superiority f